Currently, there are 383.73M common shares owned by the public and among those 289.99M shares have been available to trade.
The company’s stock has a 5-day price change of -12.21% and 16.51% over the past three months. WULF shares are trading -14.81% year to date (YTD), with the 12-month market performance down to -33.92% lower. It has a 12-month low price of $2.06 and touched a high of $9.30 over the same period. WULF has an average intraday trading volume of 38.80 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -6.88%, 9.03%, and -21.71% respectively.
Institutional ownership of TeraWulf Inc (NASDAQ: WULF) shares accounts for 51.07% of the company’s 383.73M shares outstanding.
It has a market capitalization of $1.44B and a beta (3y monthly) value of 3.13. The earnings-per-share (ttm) stands at -$0.33. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.87% over the week and 6.17% over the month.
Analysts forecast that TeraWulf Inc (WULF) will achieve an EPS of -0.07 for the current quarter, -0.07 for the next quarter and -0.18 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.12 while analysts give the company a high EPS estimate of -0.12. Comparatively, EPS for the current quarter was -0.03 a year ago. Earnings per share for the fiscal year are expected to decrease by -60.85%, and 64.14% over the next financial year.
Looking at the support for the WULF, a number of firms have released research notes about the stock. Citizens JMP stated their Mkt Outperform rating for the stock in a research note on May 22, 2025, with the firm’s price target at $7. Rosenblatt coverage for the TeraWulf Inc (WULF) stock in a research note released on April 09, 2025 offered a Buy rating with a price target of $4. Keefe Bruyette was of a view on January 08, 2025 that the stock is Mkt Perform, while Needham gave the stock Buy rating on September 04, 2024, issuing a price target of $6. Rosenblatt on their part issued Buy rating on August 14, 2024.
